Comparative analysis of MitraClip/TriClip and PASCAL in transcatheter tricuspid valve repair for tricuspid regurgitation: a systematic review and meta-analysis

Bibliographic Information
Authors: Balata M.; Gbreel M.I.; Hassan M.; Becher M.U.
Journal: BMC Cardiovascular Disorders
Publisher: BioMed Central Ltd
Publication Date: 14 October 2024
Volume / Issue: Volume 24 / Issue 1
Article No.: 557
ISSN: 14712261
DOI: 10.1186/s12872-024-04201-6
Scopus: View on Scopus
PubMed: 39402473
Document Type: Article
Access: All Open Access; Gold Open Access; Green Open Access
Authors and Affiliations
Balata M., University of Erlangen-Nuremberg, Erlangen, Germany, University of Bonn, Bonn, Germany; Gbreel M.I., Faculty of Medicine, October 6 University, Giza, Egypt; Hassan M., Theodor Bilharz Research Institute, Giza, Egypt; Becher M.U., University of Bonn, Bonn, Germany, Department of Cardiology, City hospital Solingen, Solingen, Germany
Abstract
Background: The edge-to-edge transcatheter tricuspid valve repair (TTVR) has emerged as a promising technique for the treatment of tricuspid regurgitation (TR). Despite its potential, comparative data on the performance of the novel edge-to-edge devices—MitraClip, PASCAL, and TriClip—remain controversial. In this study, we aim to evaluate the safety and efficacy of these devices in treating TR. Methods: Five databases were systematically searched up to May 2023, with an updated search conducted in May 2024. Only original studies were included in the analysis and were critically evaluated using an adapted version of the Newcastle-Ottawa Scale (NOS) for observational cohort studies and the Cochrane Risk of Bias (ROB) tool for randomized controlled trials. Results: The database search yielded 2239 studies, out of which 21 studies were included in the final analysis. These studies encompassed a total of 2178 patients who underwent TTVR using either the MitraClip, TriClip, or PASCAL devices. The risk of bias across these studies ranged from moderate to high. No significant differences were found among the three devices in terms of effective regurgitant orifice area (EROA) and tricuspid regurgitant volume. However, TriClip demonstrated statistically superior efficacy in reducing vena contracta compared to both MitraClip and PASCAL (P < 0.01) [TriClip: (MD = -7.4; 95% CI: -9.24, -5.56), MitraClip: (MD = -4.04; 95% CI: -5.03, -3.05), and PASCAL: (MD = -6.56; 95% CI: -7.76, -5.35)]. The procedural success rates and incidence of single leaflet device attachment (SLDA) were similar across all devices. Furthermore, there were no significant differences in mortality, stroke rates, or major bleeding events among the three devices. Conclusion: The TriClip outperforms the MitraClip and PASCAL in reducing vena contracta width, indicating greater effectiveness for severe tricuspid regurgitation. All devices show similar safety profiles and procedural success rates. Further research is needed to confirm these results. © The Author(s) 2024.
Keywords
Meta-analysis; MitraClip; Pascal; Transcatheter tricuspid valve repair; TriClip; Tricuspid regurgitation; Aged; Aged, 80 and over; Cardiac Catheterization; Female; Heart Valve Prosthesis; Heart Valve Prosthesis Implantation; Humans; Male; Middle Aged; Prosthesis Design; Recovery of Function; Risk Factors; Treatment Outcome; Tricuspid Valve; Tricuspid Valve Insufficiency; all cause mortality; Article; comparative effectiveness; controlled study; data quality assessment; device comparison; disease classification; disease duration; disease severity; echocardiography; fluoroscopy; heart failure; heart left ventricle ejection fraction; hospitalization; human; meta analysis; mitral valve regurgitation; multidisciplinary team; New York Heart Association class; Newcastle-Ottawa scale; Preferred Reporting Items for Systematic Reviews and Meta-Analyses; pulmonary artery systolic pressure; risk factor; six minute walk test; systematic review; transcatheter aortic valve implantation; tricuspid annular plane systolic excursion; tricuspid valve regurgitation; tricuspid valve repair; adverse event; convalescence; devices; diagnostic imaging; heart catheterization; heart valve replacement; pathophysiology; surgery; very elderly
Citation Information
Scopus Citations: 6
For comprehensive information about the Theodor Bilharz Research Institute (TBRI), its institutional activities, scientific and research achievements, clinical and hospital services, and the diverse expertise offered through its 22 specialized research and clinical departments, as well as opportunities for professional training, specialized workshops, and scientific conferences, readers are invited to visit the Institute’s official website.
The website provides regularly updated information on the Institute’s latest news, research activities, scientific initiatives, clinical services, institutional programs, and academic and professional opportunities.
English Website: https://www.tbri.sci.eg/en/
Arabic Website: https://www.tbri.sci.eg/ar/
Prepared and Uploaded by:
Abdalla F. Abdalla
Electronic Portal Unit
